Breaking News, Collaborations & Alliances

Tjoapack and Photocure Sign Agreement

CPO signs five-year agreement with Photocure for the packaging of its proprietary bladder cancer detection products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Tjoapack has signed a five-year agreement with Photocure for the packaging of its proprietary bladder cancer detection products. Hexvix/Cysview is a drug that is selectively taken up by cancer cells in the bladder making them glow bright pink during blue light cystoscopy (BLCTM). BLCTM with Hexvix/Cysview improves the detection of tumors and leads to more complete resection and less residual tumors. The contract will see Tjoapack perform the secondary packaging and assembly of product kits...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters